Perspective Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1.35 |
0.86 |
1.03 |
10.26 |
88.66 |
287.71 |
| Przychód Δ r/r |
0.00% |
-36.29% |
20.15% |
892.63% |
763.98% |
224.51% |
| Przychód (min) |
1.10 |
0.86 |
0.99 |
10.26 |
88.66 |
287.71 |
| Przychód (max) |
1.80 |
0.86 |
1.08 |
10.26 |
88.66 |
287.71 |
| EBITDA (średnia) |
-0.55 |
-0.35 |
-0.42 |
-4.16 |
-35.92 |
-116.56 |
| EBIT (średnia) |
-0.55 |
-0.35 |
-0.42 |
-4.21 |
-36.34 |
-117.93 |
| EBIT % |
-40.99% |
-40.99% |
-40.99% |
-40.99% |
-40.99% |
-40.99% |
| Zysk netto (średni) |
-55.48 |
-74.12 |
-113.58 |
-130.00 |
-54.13 |
3.54 |
| Zysk netto % |
-4108.21% |
-8614.59% |
-10987.26% |
-1266.90% |
-61.05% |
1.23% |
| EPS (średnia) |
-0.85 |
-1.15 |
-1.29 |
-1.30 |
-0.84 |
0.06 |
| Liczba analityków (Przychody) |
9 |
7 |
12 |
9 |
3 |
4 |
| Liczba analityków (EPS) |
7 |
6 |
9 |
8 |
7 |
6 |
| symbol |
CATX |
CATX |
CATX |
CATX |
CATX |
CATX |